• Explore /
  • Poster
  • / Association of polypharmacy and potential drug-drug interactions with adverse outcomes in older adults with advanced cancer receiving systemic treatment.

Association of polypharmacy and potential drug-drug interactions with adverse outcomes in older adults with advanced cancer receiving systemic treatment.

Abstract Poster

Authors

Mostafa Refaat Mohamed

Mostafa Refaat Mohamed

University of Rochester James Wilmot Cancer Institute, Rochester, NY

Mostafa Refaat Mohamed , Supriya Gupta Mohile , Katherine Juba , Hala Awad , Megan Wells , Kah Poh Loh , Marie Anne Flannery , Eva Culakova , Rachael Tylock , Nisarg Desai , Thomas Paul Bradley , Adedayo A. Onitilo , Erika E. Ramsdale

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

Geriatric Models of Care

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 12053)

DOI

10.1200/JCO.2022.40.16_suppl.12053

Abstract #

12053

Poster Bd #

299

Abstract Disclosures

Similar Posters

First Author: Eva Culakova

First Author: Noam Falbel Ponde

First Author: Ying Wang

First Author: Robert Kudlovich